These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

47 related articles for article (PubMed ID: 10226236)

  • 1. Ambulatory blood pressure monitoring: non-pharmacological and pharmacological treatment.
    Herpin D; Ragot S
    Blood Press Monit; 1996 Jun; 1(3):241-245. PubMed ID: 10226236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Twenty-four-hour ambulatory blood pressure monitoring in the evaluation of antihypertensive drugs: methodological aspects.
    Chamontin B
    Blood Press Monit; 1996 Jun; 1(3):213-216. PubMed ID: 10226229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aims of ambulatory blood pressure monitoring during phase II and III clinical trials.
    Andréjak MJ
    Blood Press Monit; 1996 Jun; 1(3):309-311. PubMed ID: 10226251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ambulatory monitoring of the blood pressure in multicenter clinical trials.
    White WB; Walsh SJ
    Blood Press Monit; 1996 Jun; 1(3):227-229. PubMed ID: 10226232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is it possible to file and approve a new antihypertensive without ambulatory blood pressure monitoring?
    Meyer-Sabellek WA
    Blood Press Monit; 1996 Jun; 1(3):317-319. PubMed ID: 10226253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conduct of therapeutic trials.
    Vaïsse B
    Blood Press Monit; 1996 Jun; 1(3):237-240. PubMed ID: 10226235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repeated measurements of non-invasive ambulatory blood pressure: distinction between reproducibility and the proper effect of placebo.
    Asmar R; Boutelant S; Chaignon M; Guedon J; Topouchian J; Mallion JM; Safar M
    Blood Press Monit; 1996 Jun; 1(3):283-288. PubMed ID: 10226245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What are the approaches for evaluating antihypertensive treatment by 24 h ambulatory blood pressure monitoring?
    Neutel JM; Smith DH; Weber MA
    Blood Press Monit; 1999; 4 Suppl 2():S23-8. PubMed ID: 10822419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ambulatory blood pressure monitoring in clinical trials.
    Staessen JA; Bieniaszewski L; Celis H; Thijs L; Fagard R
    Blood Press Monit; 1996 Jun; 1(3):223-225. PubMed ID: 10226231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ambulatory versus clinic blood pressure for the assessment of anti hypertensive efficacy in clinical trials: insights from the Val-Syst Study.
    Palatini P; Dorigatti F; Mugellini A; Spagnuolo V; Varì N; Ferrara R; Bertocchi F
    Clin Ther; 2004 Sep; 26(9):1436-45. PubMed ID: 15531006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antihypertensive effect of valsartan 80 mg and hydrochlorothiazide 12.5 mg evaluated by ambulatory blood pressure monitoring].
    Vaïsse B; Ghobrial H; Vaur L; Poncelet P; Asmar R; Herpin D; Mallion JM
    Arch Mal Coeur Vaiss; 2001 Aug; 94(8):907-12. PubMed ID: 11575229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of once-daily antihypertensive therapy.
    Myers MG
    Heart Dis; 2000; 2(2):S7-12. PubMed ID: 11728257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Level of blood pressure control in a hypertensive population when measurements are performed outside the clinical setting.
    Félix-Redondo FJ; Fernández-Bergés D; Espinosa-Garcia J; Pozuelos-Estrada J; Molina-Martínez LM; Pérez-Castán JF; Ríos-Rivera J; Valiente-Rubio JI; Gómez-de-la-Cámara A; Rodríguez-Pascual N
    Cardiol J; 2009; 16(1):57-67. PubMed ID: 19130417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Benefits of ambulatory blood pressure monitoring in the design of antihypertensive drug trials.
    Coats AJ
    Blood Press Monit; 1996 Apr; 1(2):157-160. PubMed ID: 10226219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lifestyle modifications to prevent and control hypertension. 1. Methods and an overview of the Canadian recommendations. Canadian Hypertension Society, Canadian Coalition for High Blood Pressure Prevention and Control, Laboratory Centre for Disease Control at Health Canada, Heart and Stroke Foundation of Canada.
    Campbell NR; Burgess E; Choi BC; Taylor G; Wilson E; Cléroux J; Fodor JG; Leiter LA; Spence D
    CMAJ; 1999 May; 160(9 Suppl):S1-6. PubMed ID: 10333847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical value of ambulatory blood pressure monitoring in the assessment of antihypertensive therapy.
    Waeber B; Brunner HR
    Blood Press Monit; 1999 Oct; 4(5):263-6. PubMed ID: 10547648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ambulatory blood pressure monitoring in the prediction of cardiovascular events and effects of chronotherapy: rationale and design of the MAPEC study.
    Hermida RC
    Chronobiol Int; 2007; 24(4):749-75. PubMed ID: 17701685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conduct of therapeutic trials.
    Perloff D
    Blood Press Monit; 1996 Jun; 1(3):255-257. PubMed ID: 10226239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Superior consistency of ambulatory blood pressure monitoring in children: implications for clinical trials.
    Gimpel C; Wühl E; Arbeiter K; Drozdz D; Trivelli A; Charbit M; Gellermann J; Dusek J; Jankauskiene A; Emre S; Schaefer F;
    J Hypertens; 2009 Aug; 27(8):1568-74. PubMed ID: 19550356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The trained observer better predicts daytime ABPM diastolic blood pressure in hypertensive patients than does an automated (Omron) device.
    Graves JW; Grossardt BR; Gullerud RE; Bailey KR; Feldstein J
    Blood Press Monit; 2006 Apr; 11(2):53-8. PubMed ID: 16534405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.